Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A0MJ
|
||||
Former ID |
DIB001740
|
||||
Drug Name |
Nerve growth factor
|
||||
Synonyms |
Neuleze; Nerve growth factor (recombinant); RhNGF, Genentech; NGF-beta, Genentech; Nerve growth factor (recombinant), Genentech; Nerve growth factor, Mitsubishi/Dompe/Fidia
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Terminated | [544700] | ||
Company |
Genentech Inc
|
||||
Target and Pathway | |||||
Target(s) | Beta-nerve growth factor | Target Info | Modulator | [556264] | |
Reactome | Frs2-mediated activation | ||||
ARMS-mediated activation | |||||
NRAGE signals death through JNK | |||||
p75NTR negatively regulates cell cycle via SC1 | |||||
PI3K/AKT activation | |||||
NADE modulates death signalling | |||||
NRIF signals cell death from the nucleus | |||||
p75NTR recruits signalling complexes | |||||
NF-kB is activated and signals survival | |||||
Axonal growth stimulation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.